Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 73 entries
Sorted by: Best Match Show Resources per page
Cancer Associated Fibroblasts and Senescent Thyroid Cells in the Invasive Front of Thyroid Carcinoma.

Cancers

Minna E, Brich S, Todoerti K, Pilotti S, Collini P, Bonaldi E, Romeo P, Cecco L, Dugo M, Perrone F, Busico A, Vingiani A, Bersani I, Anichini A, Mortarini R, Neri A, Pruneri G, Greco A, Borrello MG.
PMID: 31906302
Cancers (Basel). 2020 Jan 01;12(1). doi: 10.3390/cancers12010112.

Thyroid carcinoma (TC) comprises several histotypes with different aggressiveness, from well (papillary carcinoma, PTC) to less differentiated forms (poorly differentiated and anaplastic thyroid carcinoma, PDTC and ATC, respectively). Previous reports have suggested a functional role for cancer-associated fibroblasts (CAFs)...

Cite
Minna E, Brich S, Todoerti K, et al. Cancer Associated Fibroblasts and Senescent Thyroid Cells in the Invasive Front of Thyroid Carcinoma. Cancers (Basel). 2020;12(1)doi: 10.3390/cancers12010112.
Minna, E., Brich, S., Todoerti, K., Pilotti, S., Collini, P., Bonaldi, E., Romeo, P., Cecco, L., Dugo, M., Perrone, F., Busico, A., Vingiani, A., Bersani, I., Anichini, A., Mortarini, R., Neri, A., Pruneri, G., Greco, A., & Borrello, M. G. (2020). Cancer Associated Fibroblasts and Senescent Thyroid Cells in the Invasive Front of Thyroid Carcinoma. Cancers, 12(1), . https://doi.org/10.3390/cancers12010112
Minna, Emanuela, et al. "Cancer Associated Fibroblasts and Senescent Thyroid Cells in the Invasive Front of Thyroid Carcinoma." Cancers vol. 12,1 (2020). doi: https://doi.org/10.3390/cancers12010112
Minna E, Brich S, Todoerti K, Pilotti S, Collini P, Bonaldi E, Romeo P, Cecco L, Dugo M, Perrone F, Busico A, Vingiani A, Bersani I, Anichini A, Mortarini R, Neri A, Pruneri G, Greco A, Borrello MG. Cancer Associated Fibroblasts and Senescent Thyroid Cells in the Invasive Front of Thyroid Carcinoma. Cancers (Basel). 2020 Jan 01;12(1). doi: 10.3390/cancers12010112. PMID: 31906302; PMCID: PMC7016563.
Copy Download .nbib Format: NLM
The Added Value of Baseline Circulating Tumor DNA Profiling in Patients with Molecularly Hyperselected, Left-sided Metastatic Colorectal Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research

Manca P, Corallo S, Busico A, Lonardi S, Corti F, Antoniotti C, Procaccio L, Clavarezza M, Smiroldo V, Tomasello G, Murialdo R, Sartore-Bianchi A, Racca P, Pagani F, Randon G, Martinetti A, Sottotetti E, Palermo F, Perrone F, Tamborini E, Prisciandaro M, Raimondi A, Di Bartolomeo M, Morano F, Pietrantonio F.
PMID: 33547199
Clin Cancer Res. 2021 May 01;27(9):2505-2514. doi: 10.1158/1078-0432.CCR-20-4699. Epub 2021 Feb 05.

PURPOSE: The routine use of liquid biopsy is not recommended for the choice of initial treatment for patients with metastatic colorectal cancer (mCRC).EXPERIMENTAL DESIGN: We included patients with left-sided, RESULTS: Ten and 15 of 120 patients had a mutation...

Cite
Manca P, Corallo S, Busico A, et al. The Added Value of Baseline Circulating Tumor DNA Profiling in Patients with Molecularly Hyperselected, Left-sided Metastatic Colorectal Cancer. Clin Cancer Res. 2021;27(9):2505-2514doi: 10.1158/1078-0432.CCR-20-4699.
Manca, P., Corallo, S., Busico, A., Lonardi, S., Corti, F., Antoniotti, C., Procaccio, L., Clavarezza, M., Smiroldo, V., Tomasello, G., Murialdo, R., Sartore-Bianchi, A., Racca, P., Pagani, F., Randon, G., Martinetti, A., Sottotetti, E., Palermo, F., Perrone, F., Tamborini, E., Prisciandaro, M., Raimondi, A., Di Bartolomeo, M., Morano, F., & Pietrantonio, F. (2021). The Added Value of Baseline Circulating Tumor DNA Profiling in Patients with Molecularly Hyperselected, Left-sided Metastatic Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(9), 2505-2514. https://doi.org/10.1158/1078-0432.CCR-20-4699
Manca, Paolo, et al. "The Added Value of Baseline Circulating Tumor DNA Profiling in Patients with Molecularly Hyperselected, Left-sided Metastatic Colorectal Cancer." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,9 (2021): 2505-2514. doi: https://doi.org/10.1158/1078-0432.CCR-20-4699
Manca P, Corallo S, Busico A, Lonardi S, Corti F, Antoniotti C, Procaccio L, Clavarezza M, Smiroldo V, Tomasello G, Murialdo R, Sartore-Bianchi A, Racca P, Pagani F, Randon G, Martinetti A, Sottotetti E, Palermo F, Perrone F, Tamborini E, Prisciandaro M, Raimondi A, Di Bartolomeo M, Morano F, Pietrantonio F. The Added Value of Baseline Circulating Tumor DNA Profiling in Patients with Molecularly Hyperselected, Left-sided Metastatic Colorectal Cancer. Clin Cancer Res. 2021 May 01;27(9):2505-2514. doi: 10.1158/1078-0432.CCR-20-4699. Epub 2021 Feb 05. PMID: 33547199.
Copy Download .nbib Format: NLM
Author Correction: Loss of ELF5-FBXW7 stabilizes IFNGR1 to promote the growth and metastasis of triple-negative breast cancer through interferon-γ signalling.

Nature cell biology

Singh S, Kumar S, Srivastava RK, Nandi A, Thacker G, Murali H, Kim S, Baldeon M, Tobias J, Blanco MA, Saffie R, Zaidi MR, Sinha S, Busino L, Fuchs SY, Chakrabarti R.
PMID: 34349253
Nat Cell Biol. 2021 Sep;23(9):1048. doi: 10.1038/s41556-021-00733-7.

No abstract available.

Cite
Singh S, Kumar S, Srivastava RK, et al. Author Correction: Loss of ELF5-FBXW7 stabilizes IFNGR1 to promote the growth and metastasis of triple-negative breast cancer through interferon-γ signalling. Nat Cell Biol. 2021;23(9):1048doi: 10.1038/s41556-021-00733-7.
Singh, S., Kumar, S., Srivastava, R. K., Nandi, A., Thacker, G., Murali, H., Kim, S., Baldeon, M., Tobias, J., Blanco, M. A., Saffie, R., Zaidi, M. R., Sinha, S., Busino, L., Fuchs, S. Y., & Chakrabarti, R. (2021). Author Correction: Loss of ELF5-FBXW7 stabilizes IFNGR1 to promote the growth and metastasis of triple-negative breast cancer through interferon-γ signalling. Nature cell biology, 23(9), 1048. https://doi.org/10.1038/s41556-021-00733-7
Singh, Snahlata, et al. "Author Correction: Loss of ELF5-FBXW7 stabilizes IFNGR1 to promote the growth and metastasis of triple-negative breast cancer through interferon-γ signalling." Nature cell biology vol. 23,9 (2021): 1048. doi: https://doi.org/10.1038/s41556-021-00733-7
Singh S, Kumar S, Srivastava RK, Nandi A, Thacker G, Murali H, Kim S, Baldeon M, Tobias J, Blanco MA, Saffie R, Zaidi MR, Sinha S, Busino L, Fuchs SY, Chakrabarti R. Author Correction: Loss of ELF5-FBXW7 stabilizes IFNGR1 to promote the growth and metastasis of triple-negative breast cancer through interferon-γ signalling. Nat Cell Biol. 2021 Sep;23(9):1048. doi: 10.1038/s41556-021-00733-7. PMID: 34349253.
Copy Download .nbib Format: NLM
[Cutaneous reactions to a marine environment].

Gazzetta internazionale di medicina e chirurgia

BUSINCO L, GERACI V.
PMID: 14041205
Gazz Int Med Chir. 1963 Jun;67:1326-31.

No abstract available.

Cite
BUSINCO L, GERACI V. [Cutaneous reactions to a marine environment]. Gazz Int Med Chir. 1963;67:1326-31
BUSINCO, L., & GERACI, V. (1963). [Cutaneous reactions to a marine environment]. Gazzetta internazionale di medicina e chirurgia, 671326-31.
BUSINCO, L, and GERACI, V. "[Cutaneous reactions to a marine environment]." Gazzetta internazionale di medicina e chirurgia vol. 67 (1963): 1326-31.
BUSINCO L, GERACI V. [Cutaneous reactions to a marine environment]. Gazz Int Med Chir. 1963 Jun;67:1326-31. Italian. PMID: 14041205.
Copy Download .nbib Format: NLM
Improved Prognostic Prediction in Never-Smoker Lung Cancer Patients by Integration of a Systemic Inflammation Marker with Tumor Immune Contexture Analysis.

Cancers

Milione M, Boeri M, Cantarutti A, Centonze G, Busico A, Suatoni P, Garzone G, Cattaneo L, Tamborini E, Perrone F, Mangogna A, Corrao G, Pruneri G, Sozzi G, Anichini A, Pastorino U.
PMID: 32646072
Cancers (Basel). 2020 Jul 07;12(7). doi: 10.3390/cancers12071828.

Almost 25% of lung cancers (LCs) occur in never-smokers. LC inflammatory profile, based on plasma C-reactive protein levels (CRP), predicts mortality, independently by smoking-status. We hypothesized that: CRP could be associated with tumor immune contexture (TIC) in never-smokers and...

Cite
Milione M, Boeri M, Cantarutti A, et al. Improved Prognostic Prediction in Never-Smoker Lung Cancer Patients by Integration of a Systemic Inflammation Marker with Tumor Immune Contexture Analysis. Cancers (Basel). 2020;12(7)doi: 10.3390/cancers12071828.
Milione, M., Boeri, M., Cantarutti, A., Centonze, G., Busico, A., Suatoni, P., Garzone, G., Cattaneo, L., Tamborini, E., Perrone, F., Mangogna, A., Corrao, G., Pruneri, G., Sozzi, G., Anichini, A., & Pastorino, U. (2020). Improved Prognostic Prediction in Never-Smoker Lung Cancer Patients by Integration of a Systemic Inflammation Marker with Tumor Immune Contexture Analysis. Cancers, 12(7), . https://doi.org/10.3390/cancers12071828
Milione, Massimo, et al. "Improved Prognostic Prediction in Never-Smoker Lung Cancer Patients by Integration of a Systemic Inflammation Marker with Tumor Immune Contexture Analysis." Cancers vol. 12,7 (2020). doi: https://doi.org/10.3390/cancers12071828
Milione M, Boeri M, Cantarutti A, Centonze G, Busico A, Suatoni P, Garzone G, Cattaneo L, Tamborini E, Perrone F, Mangogna A, Corrao G, Pruneri G, Sozzi G, Anichini A, Pastorino U. Improved Prognostic Prediction in Never-Smoker Lung Cancer Patients by Integration of a Systemic Inflammation Marker with Tumor Immune Contexture Analysis. Cancers (Basel). 2020 Jul 07;12(7). doi: 10.3390/cancers12071828. PMID: 32646072; PMCID: PMC7408913.
Copy Download .nbib Format: NLM
Structural Characterization of Electron Donors in Ziegler-Natta Catalysts.

The journal of physical chemistry. C, Nanomaterials and interfaces

Blaakmeer ESM, Antinucci G, Correa A, Busico V, van Eck ERH, Kentgens APM.
PMID: 29568341
J Phys Chem C Nanomater Interfaces. 2018 Mar 15;122(10):5525-5536. doi: 10.1021/acs.jpcc.7b12667. Epub 2018 Feb 21.

Ziegler-Natta catalysis is a very important industrial process for the production of polyolefins. However, the catalysts are not well-understood at the molecular level. Yet, atomic-scale structural information is of pivotal importance for rational catalyst development. We applied a solid-state...

Cite
Blaakmeer ESM, Antinucci G, Correa A, et al. Structural Characterization of Electron Donors in Ziegler-Natta Catalysts. J Phys Chem C Nanomater Interfaces. 2018;122(10):5525-5536doi: 10.1021/acs.jpcc.7b12667.
Blaakmeer, E. S. M., Antinucci, G., Correa, A., Busico, V., van Eck, E. R. H., & Kentgens, A. P. M. (2018). Structural Characterization of Electron Donors in Ziegler-Natta Catalysts. The journal of physical chemistry. C, Nanomaterials and interfaces, 122(10), 5525-5536. https://doi.org/10.1021/acs.jpcc.7b12667
Blaakmeer, E S Merijn, et al. "Structural Characterization of Electron Donors in Ziegler-Natta Catalysts." The journal of physical chemistry. C, Nanomaterials and interfaces vol. 122,10 (2018): 5525-5536. doi: https://doi.org/10.1021/acs.jpcc.7b12667
Blaakmeer ESM, Antinucci G, Correa A, Busico V, van Eck ERH, Kentgens APM. Structural Characterization of Electron Donors in Ziegler-Natta Catalysts. J Phys Chem C Nanomater Interfaces. 2018 Mar 15;122(10):5525-5536. doi: 10.1021/acs.jpcc.7b12667. Epub 2018 Feb 21. PMID: 29568341; PMCID: PMC5857925.
Copy Download .nbib Format: NLM
Corrigendum: Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group.

Frontiers in oncology

Racanelli D, Brenca M, Baldazzi D, Goeman F, Casini B, De Angelis B, Guercio M, Milano GM, Tamborini E, Busico A, Dagrada G, Garofalo C, Caruso C, Brunello A, Pignochino Y, Berrino E, Grignani G, Scotlandi K, Parra A, Hattinger CM, Ibrahim T, Mercatali L, De Vita A, Carriero MV, Pallocca M, Loria R, Covello R, Sbaraglia M, Dei Tos AP, Falcioni R, Maestro R.
PMID: 32656080
Front Oncol. 2020 Jun 23;10:944. doi: 10.3389/fonc.2020.00944. eCollection 2020.

[This corrects the article DOI: 10.3389/fonc.2020.00489.].

Cite
Racanelli D, Brenca M, Baldazzi D, et al. Corrigendum: Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group. Front Oncol. 2020;10:944doi: 10.3389/fonc.2020.00944.
Racanelli, D., Brenca, M., Baldazzi, D., Goeman, F., Casini, B., De Angelis, B., Guercio, M., Milano, G. M., Tamborini, E., Busico, A., Dagrada, G., Garofalo, C., Caruso, C., Brunello, A., Pignochino, Y., Berrino, E., Grignani, G., Scotlandi, K., Parra, A., Hattinger, C. M., Ibrahim, T., Mercatali, L., De Vita, A., Carriero, M. V., Pallocca, M., Loria, R., Covello, R., Sbaraglia, M., Dei Tos, A. P., Falcioni, R., & Maestro, R. (2020). Corrigendum: Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group. Frontiers in oncology, 10944. https://doi.org/10.3389/fonc.2020.00944
Racanelli, Dominga, et al. "Corrigendum: Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group." Frontiers in oncology vol. 10 (2020): 944. doi: https://doi.org/10.3389/fonc.2020.00944
Racanelli D, Brenca M, Baldazzi D, Goeman F, Casini B, De Angelis B, Guercio M, Milano GM, Tamborini E, Busico A, Dagrada G, Garofalo C, Caruso C, Brunello A, Pignochino Y, Berrino E, Grignani G, Scotlandi K, Parra A, Hattinger CM, Ibrahim T, Mercatali L, De Vita A, Carriero MV, Pallocca M, Loria R, Covello R, Sbaraglia M, Dei Tos AP, Falcioni R, Maestro R. Corrigendum: Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group. Front Oncol. 2020 Jun 23;10:944. doi: 10.3389/fonc.2020.00944. eCollection 2020. PMID: 32656080; PMCID: PMC7324988.
Copy Download .nbib Format: NLM
Design of stereoselective Ziegler-Natta propene polymerization catalysts.

Proceedings of the National Academy of Sciences of the United States of America

Busico V, Cipullo R, Pellecchia R, Ronca S, Roviello G, Talarico G.
PMID: 17032770
Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15321-6. doi: 10.1073/pnas.0602856103. Epub 2006 Oct 10.

After five decades of largely serendipitous (albeit formidable) progress, catalyst design in Ziegler-Natta olefin polymerization, i.e., the rational implementation of new active species to target predetermined polyolefin architectures, has ultimately become a realistic ambition, thanks to a much deeper...

Cite
Busico V, Cipullo R, Pellecchia R, et al. Design of stereoselective Ziegler-Natta propene polymerization catalysts. Proc Natl Acad Sci U S A. 2006;103(42):15321-6doi: 10.1073/pnas.0602856103.
Busico, V., Cipullo, R., Pellecchia, R., Ronca, S., Roviello, G., & Talarico, G. (2006). Design of stereoselective Ziegler-Natta propene polymerization catalysts. Proceedings of the National Academy of Sciences of the United States of America, 103(42), 15321-6. https://doi.org/10.1073/pnas.0602856103
Busico, Vincenzo, et al. "Design of stereoselective Ziegler-Natta propene polymerization catalysts." Proceedings of the National Academy of Sciences of the United States of America vol. 103,42 (2006): 15321-6. doi: https://doi.org/10.1073/pnas.0602856103
Busico V, Cipullo R, Pellecchia R, Ronca S, Roviello G, Talarico G. Design of stereoselective Ziegler-Natta propene polymerization catalysts. Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15321-6. doi: 10.1073/pnas.0602856103. Epub 2006 Oct 10. PMID: 17032770; PMCID: PMC1622825.
Copy Download .nbib Format: NLM
Oncoimmunology Meets Organs-on-Chip.

Frontiers in molecular biosciences

Mattei F, Andreone S, Mencattini A, De Ninno A, Businaro L, Martinelli E, Schiavoni G.
PMID: 33842539
Front Mol Biosci. 2021 Mar 26;8:627454. doi: 10.3389/fmolb.2021.627454. eCollection 2021.

Oncoimmunology represents a biomedical research discipline coined to study the roles of immune system in cancer progression with the aim of discovering novel strategies to arm it against the malignancy. Infiltration of immune cells within the tumor microenvironment is...

Cite
Mattei F, Andreone S, Mencattini A, et al. Oncoimmunology Meets Organs-on-Chip. Front Mol Biosci. 2021;8:627454doi: 10.3389/fmolb.2021.627454.
Mattei, F., Andreone, S., Mencattini, A., De Ninno, A., Businaro, L., Martinelli, E., & Schiavoni, G. (2021). Oncoimmunology Meets Organs-on-Chip. Frontiers in molecular biosciences, 8627454. https://doi.org/10.3389/fmolb.2021.627454
Mattei, Fabrizio, et al. "Oncoimmunology Meets Organs-on-Chip." Frontiers in molecular biosciences vol. 8 (2021): 627454. doi: https://doi.org/10.3389/fmolb.2021.627454
Mattei F, Andreone S, Mencattini A, De Ninno A, Businaro L, Martinelli E, Schiavoni G. Oncoimmunology Meets Organs-on-Chip. Front Mol Biosci. 2021 Mar 26;8:627454. doi: 10.3389/fmolb.2021.627454. eCollection 2021. PMID: 33842539; PMCID: PMC8032996.
Copy Download .nbib Format: NLM
The origin of Uranium in groundwater of the eastern Halkidiki region, northern Greece.

The Science of the total environment

Kazakis N, Busico G, Ntona MM, Philippou K, Kaprara E, Mitrakas M, Bannenberg M, Ioannidou A, Pashalidis I, Colombani N, Mastrocicco M, Voudouris K.
PMID: 34942244
Sci Total Environ. 2021 Dec 21;812:152445. doi: 10.1016/j.scitotenv.2021.152445. Epub 2021 Dec 21.

Uranium (U) pollution in groundwater has become a serious problem worldwide. Even in low concentrations, U has both radiological and toxicological impacts on human health. In this study an integrated hydrogeological approach was applied to conceptualize an aquifer system,...

Cite
Kazakis N, Busico G, Ntona MM, et al. The origin of Uranium in groundwater of the eastern Halkidiki region, northern Greece. Sci Total Environ. 2021;812:152445doi: 10.1016/j.scitotenv.2021.152445.
Kazakis, N., Busico, G., Ntona, M. M., Philippou, K., Kaprara, E., Mitrakas, M., Bannenberg, M., Ioannidou, A., Pashalidis, I., Colombani, N., Mastrocicco, M., & Voudouris, K. (2021). The origin of Uranium in groundwater of the eastern Halkidiki region, northern Greece. The Science of the total environment, 812152445. https://doi.org/10.1016/j.scitotenv.2021.152445
Kazakis, Nerantzis, et al. "The origin of Uranium in groundwater of the eastern Halkidiki region, northern Greece." The Science of the total environment vol. 812 (2021): 152445. doi: https://doi.org/10.1016/j.scitotenv.2021.152445
Kazakis N, Busico G, Ntona MM, Philippou K, Kaprara E, Mitrakas M, Bannenberg M, Ioannidou A, Pashalidis I, Colombani N, Mastrocicco M, Voudouris K. The origin of Uranium in groundwater of the eastern Halkidiki region, northern Greece. Sci Total Environ. 2021 Dec 21;812:152445. doi: 10.1016/j.scitotenv.2021.152445. Epub 2021 Dec 21. PMID: 34942244.
Copy Download .nbib Format: NLM
Benefit from anti-EGFRs in .

ESMO open

Cremolini C, Benelli M, Fontana E, Pagani F, Rossini D, Fucà G, Busico A, Conca E, Di Donato S, Loupakis F, Schirripa M, Lonardi S, Borelli B, Ongaro E, Eason K, Morano F, Casagrande M, Fassan M, Sadanandam A, de Braud F, Falcone A, Pietrantonio F.
PMID: 30962964
ESMO Open. 2019 Mar 08;4(2):e000489. doi: 10.1136/esmoopen-2019-000489. eCollection 2019.

No abstract available.

Cite
Cremolini C, Benelli M, Fontana E, et al. Benefit from anti-EGFRs in . ESMO Open. 2019;4(2):e000489doi: 10.1136/esmoopen-2019-000489.
Cremolini, C., Benelli, M., Fontana, E., Pagani, F., Rossini, D., Fucà, G., Busico, A., Conca, E., Di Donato, S., Loupakis, F., Schirripa, M., Lonardi, S., Borelli, B., Ongaro, E., Eason, K., Morano, F., Casagrande, M., Fassan, M., Sadanandam, A., de Braud, F., Falcone, A., & Pietrantonio, F. (2019). Benefit from anti-EGFRs in . ESMO open, 4(2), e000489. https://doi.org/10.1136/esmoopen-2019-000489
Cremolini, Chiara, et al. "Benefit from anti-EGFRs in ." ESMO open vol. 4,2 (2019): e000489. doi: https://doi.org/10.1136/esmoopen-2019-000489
Cremolini C, Benelli M, Fontana E, Pagani F, Rossini D, Fucà G, Busico A, Conca E, Di Donato S, Loupakis F, Schirripa M, Lonardi S, Borelli B, Ongaro E, Eason K, Morano F, Casagrande M, Fassan M, Sadanandam A, de Braud F, Falcone A, Pietrantonio F. Benefit from anti-EGFRs in . ESMO Open. 2019 Mar 08;4(2):e000489. doi: 10.1136/esmoopen-2019-000489. eCollection 2019. PMID: 30962964; PMCID: PMC6435314.
Copy Download .nbib Format: NLM
Analysis of the audiological characteristics and comorbidity in patients with chronic tinnitus.

Audiology research

Pavaci S, Tortorella F, Fioretti AB, Angelone AM, Businco LDR, Lauriello M, Eibenstein A.
PMID: 31929867
Audiol Res. 2019 Dec 19;9(2):231. doi: 10.4081/audiores.2019.231. eCollection 2019 Sep 02.

Tinnitus is defined as

Cite
Pavaci S, Tortorella F, Fioretti AB, et al. Analysis of the audiological characteristics and comorbidity in patients with chronic tinnitus. Audiol Res. 2019;9(2):231doi: 10.4081/audiores.2019.231.
Pavaci, S., Tortorella, F., Fioretti, A. B., Angelone, A. M., Businco, L. D. R., Lauriello, M., & Eibenstein, A. (2019). Analysis of the audiological characteristics and comorbidity in patients with chronic tinnitus. Audiology research, 9(2), 231. https://doi.org/10.4081/audiores.2019.231
Pavaci, Silva, et al. "Analysis of the audiological characteristics and comorbidity in patients with chronic tinnitus." Audiology research vol. 9,2 (2019): 231. doi: https://doi.org/10.4081/audiores.2019.231
Pavaci S, Tortorella F, Fioretti AB, Angelone AM, Businco LDR, Lauriello M, Eibenstein A. Analysis of the audiological characteristics and comorbidity in patients with chronic tinnitus. Audiol Res. 2019 Dec 19;9(2):231. doi: 10.4081/audiores.2019.231. eCollection 2019 Sep 02. PMID: 31929867; PMCID: PMC6945072.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 73 entries